Bioinformatics, Gene and In-Vivo - Clinical Research Informer

Astellas teams up with UK biotech Mogrify on hearing loss project

pharmaphorum

JULY 5, 2022

The two partners will take an in vivo approach to the problem of so-called sensorineural hearing loss (SNHL) looking at ways to replace sound-detecting hair cells in the inner ear (cochlea) that become damaged in this type of deafness. An estimated 1.57 Astellas is already working on other approaches to treating hearing loss.

In-Vivo

In-Vivo Bioinformatics Genetics Licensing

Emerging Trends in Protein Expression Systems: Growth Opportunities And Future Outlook

Roots Analysis

JANUARY 27, 2025

Gene Identification: The process starts with identifying the gene that codes for the desired protein i.e. gene of interest. This can be done through various techniques such as PCR, DNA sequencing or gene synthesis. Considering their vast potential, close to 50% of the top selling drugs in 2023 were protein therapeutics.

Protein

Protein Reagent Marketing Gene

Clinical Research Informer

Astellas teams up with UK biotech Mogrify on hearing loss project

Emerging Trends in Protein Expression Systems: Growth Opportunities And Future Outlook

Webinars

Stay Connected